Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
出版年份 2011 全文链接
标题
Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
作者
关键词
-
出版物
BLOOD
Volume 117, Issue 25, Pages 6856-6865
出版商
American Society of Hematology
发表日期
2011-05-05
DOI
10.1182/blood-2011-01-330852
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
- (2010) Amy K Wiglesworth et al. ANNALS OF PHARMACOTHERAPY
- Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
- (2010) O. Winter et al. BLOOD
- A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation
- (2009) M. Gupta et al. BLOOD
- The microenvironment in mature B-cell malignancies: a target for new treatment strategies
- (2009) J. A. Burger et al. BLOOD
- APRIL is overexpressed in cancer: link with tumor progression
- (2009) Jérôme Moreaux et al. BMC CANCER
- APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
- (2009) Jérôme Moreaux et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
- (2009) Fiona C. Kimberley et al. FASEB JOURNAL
- Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
- (2009) I. Nestorov et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
- (2009) C Pena-Rossi et al. LUPUS
- APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
- (2008) E. Belnoue et al. BLOOD
- Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
- (2008) Seok Jin Kim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Thymus-independent class switch recombination is affected by APRIL
- (2008) Gijs Hardenberg et al. IMMUNOLOGY AND CELL BIOLOGY
- “APRIL hath put a spring of youth in everything”: Relevance of APRIL for survival
- (2008) Fiona C. Kimberley et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia
- (2008) Stefano Molica et al. LEUKEMIA RESEARCH
- Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
- (2008) Richard Furie et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now